featured
Rituximab as an Adjuvant Therapy for Pemphigus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rituximab as an Adjuvant Therapy for Pemphigus: Experience in 61 Patients From a Single Center With Long-Term Follow-Up
Int. J. Dermatol 2019 Jun 30;[EPub Ahead of Print], VK Sharma, V Gupta, N Bhari, V SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.